Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07438912

Mind After Midnight

This study examines whether wakefulness during the biological night (2:00-4:00 AM) is associated with increased negative mood, impaired decision-making, and suicidal thoughts. Adults with a history of suicidal ideation in the past six months will complete laboratory and home-based assessments under varying levels of sleep pressure. Participants will be evaluated during late-night wakefulness and under conditions of both higher and lower sleep pressure. The goal of the study is to better understand the biological and behavioral mechanisms that may contribute to elevated suicide risk during nocturnal wakefulness.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–55 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Arizona - Center for Sleep, Circadian, and Neuroscience Research

Tucson, Arizona, 85724, United States

Location status: Recruiting

Location contact

Darilyn Rivera-Collazo, MS

CONTACT

[email protected]

520-626-4746

About this study

Suicide risk is elevated during the biological night, particularly between 2:00 and 4:00 AM. Observational and epidemiologic data suggest that nocturnal wakefulness is associated with increased negative affect, impaired decision-making, and greater suicidal ideation. The "Mind After Midnight" hypothesis proposes that wakefulness during the biological night exposes individuals to a combination of circadian vulnerability and homeostatic sleep pressure that contributes to emotional and cognitive dysregulation.

This study will recruit approximately 90 adults with a history of suicidal ideation in the past six months. Participants will complete both home-based and laboratory-based procedures. Laboratory assessments will evaluate mood, hopelessness, suicidal ideation, impulsivity, and decision-making at different times of day, including 2:00-4:00 AM. To examine the role of homeostatic sleep pressure, participants will complete late-night assessments under two conditions: (1) high sleep pressure (remaining awake until 2:00 AM) and (2) low sleep pressure (sleeping and being awakened at 2:00 AM). Circadian factors will be assessed using behavioral measures and physiologic markers, including melatonin.

The goal of the study is to experimentally test whether nocturnal wakefulness contributes to suicide-associated cognitive and affective processes and to identify underlying chronobiological mechanisms.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18-55 years
  • History of suicidal ideation within the past 6 months
  • Habitual bedtime between 9:00 PM and 1:00 AM
  • Habitual wake time between 6:00 AM and 9:00 AM
  • Ability to provide informed consent

Exclusion criteria

  • Current suicidal intent requiring immediate clinical intervention
  • Diagnosis of a primary sleep disorder (e.g., untreated obstructive sleep apnea, narcolepsy)
  • Bipolar disorder or psychotic disorder
  • Substance use disorder within the past 3 months
  • Use of medications that significantly affect sleep or circadian rhythms
  • Night shift work or transmeridian travel within the past month
  • Medical or neurological condition that would interfere with participation
  • Pregnancy

Treatment and study plan

Sleep Pressure Manipulation

Behavioral

Participants undergo an experimental manipulation of homeostatic sleep pressure involving controlled wakefulness or scheduled awakening during the biological night. Mood, suicidal ideation, impulsivity, and decision-making are assessed during overnight laboratory sessions.

Primary outcomes

  1. Feelings of Hopelessness

    Time frame: Visit 1(day 2, night 2), Visit 2 (day 2, night 2)

    Total score on the BECK Hopelessness scale (BHS)

  2. Impaired Executive Function

    Time frame: Visit 1(day 2, night 2), Visit 2 (day 2, night 2)

    BART total score

  3. Negative Mood

    Time frame: Visit 1(day 2, night 2), Visit 2 (day 2, night 2)

    PANAS negative affect score

Study contacts

Contact information is provided by the study sponsor or research team.

Darilyn Rivera-Collazo, MS

CONTACT

[email protected]

5206264746

Denisse Armenta

CONTACT

[email protected]

5206261737

Sponsors and collaborators

Lead sponsor

University of Arizona

Other

Collaborators

  • National Institute of Mental Health (NIMH)

Registry information

Official study title

The Mind After Midnight: Mechanistic Examination of Nocturnal Wakefulness as a Suicide Risk Factor

Acronym: MaM

Important dates

Study start
2026
Primary completion
2029
Study completion
2029
First posted
Feb 27, 2026
Registry last updated
May 22, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.